Construction of Adjacent Quaternary and Tertiary Stereocenters
483
J = 14.2, 2H), 7.18–7.35 (m, 5H); 13C NMR (CDCl3):
d = 13.9 (CH3), 19.1 (CH2), 31.6 (CH2), 32.6 (CH2), 37.9
(CH2), 42.1 (CH), 42.2 (CH2), 60.6 (C), 62.0 (CH2), 127.7
(CH), 128.3 (CH, 2C), 128.5 (CH, 2C), 135.4 (C), 169.5 (C),
175.0 (C), 177.0 (C), 213.5 (C); IR: m = 3641, 3462, 3030,
2979, 1749, 1704, 1601,1585, 1496, 1455, 1431, 1400,
1345, 1314, 1228, 1169, 1112, 1021, 919, 830, 696, 633,
477 cm-1; HRMS: m/z calcd for C19H21NO5: 343.14197;
found: 343.14173; elemental analysis calcd (%) for
C19H21NO5: C 66.47, H 6.12, N 4.08; found: C 66.55, H
6.14, N 4.01.
sminor = 23.2 min, smajor = 30.8 min; minor diastereomer:
sminor = 33.2 min, smajor = 44.5 min]. H NMR (CDCl3):
1
d = 1.22 (t, J = 7.2, 3H), 1.50 (s, 3H), 2.24 (s, 3H), 2.44
(dd, J = 6.0, 18.4, 1H), 2.85 (dd, J = 9.2, 18.4, 1H), 3.37
(dd, J = 6.0, 9.2, 1H), 4.18 (q, J = 7.2, 2H), 4.61 4.67
(AB, J = 14.0, 2H), 7.23–7.40 (m, 5H); 13C NMR
(CDCl3): d = 13.9 (CH3), 18.9 (CH3), 26.8 (CH3), 32.4
(CH2), 42.4 (CH2), 44.9(CH), 61.2 (C), 62.2 (CH2), 127.8
(CH), 128.5 (CH, 2C), 128.7 (CH, 2C), 135.6 (C), 170.7
(C), 175.2 (C), 177.0 (C), 204.2 (C); IR: m = 3462, 3033,
2983, 2941, 2565, 1957, 1775, 1701, 1605, 1585, 1497,
1455, 1431, 1401, 1352, 1314, 1293, 1171, 1096, 1018,
972, 931, 894, 757, 697 cm-1; HRMS: m/z calcd for
C18H21NO5: 331.14197; found: 331.14163; elemental
analysis calcd (%) for C18H21NO5: C 65.26, H 6.34, N
4.23; found: C 65.34, H 6.23, N 4.20.
Methyl
1-(1-benzyl-2,5-dioxopyrrolidin-3-yl)-2-oxo-
2,3-dihydro-1H-indene-1-carboxylate, 4a: A colourless
solid. [HPLC analysis on a Daicel Chiralpak AD-H col-
umn: hexane/i-PrOH = 75/25, flow rate 0.75 mL/min,
k = 214 nm; major diastereomer: smajor = 18.5 min, smi-
= 21.2 min; minor diastereomer: smajor = 25.5 min,
3-(1-acetyl-2-oxocyclopentyl)-1-benzylpyrrolidine-2,5-
dione, 4d: A colourless foam. [HPLC analysis on a Daicel
Chiralpak AD-H column: hexane/i-PrOH = 75/25, flow
rate 0.75 mL/min, k = 214 nm; major diastereomer: smi-
nor
sminor = 27.5 min]. 1H NMR (CDCl3): d = 2.50 (dd,
J = 6.0, 18.0, 1H), 2.88 (dd, J = 9.2, 18.0, 1H), 3.55 3.61
(AB, J = 22.8, 2H), 3.70 (s, 3H), 3.94 (dd, J = 6.0, 9.2,
1H), 4.52 4.58 (AB, J = 14.0, 2H), 7.02–7.35 (m, 9H); 13
C
= 17.5 min, smajor = 18.1 min; minor diastereomer:
sminor = 16.2 min, smajor = 16.6 min]. H NMR (CDCl3):
nor
1
NMR (CDCl3): d = 32.1 (CH2), 42.5 (CH2), 43.1 (CH2),
44.6 (CH), 53.4 (CH3), 64.8 (C), 124.5 (CH), 125.1 (CH),
127.9 (CH), 128.3 (CH), 128.6 (CH, 2C), 128.7 (CH, 2C),
129.3 (CH), 135.3 (C), 137.1 (C), 137.5 (C), 168.3 (C),
174.7 (C), 175.9 (C), 209.6 (C); HRMS: m/z calcd for
C22H19NO5: 377.12632; found: 377.12603; elemental
analysis calcd (%) for C22H19NO5: C 70.03, H 5.04, N
3.71; found: C 70.15, H 5.02, N 3.67.
d = 1.80-2.00 (m, 3H), 2.19 (s, 3H), 2.35 (dd, J = 6.4,
18.4, 1H), 2.40–2.57 (m, 3H), 2.74 (dd, J = 9.2, 18.4, 1H),
3.55 (dd, J = 6.4, 9.2, 1H), 4.60 4.66 (AB, J = 14.0, 2H),
7.24–7.39 (m, 5H); 13C NMR (CDCl3): d = 19.4 (CH2),
26.2 (CH3), 28.8 (CH2), 31.8 (CH2), 38.4 (CH2), 42.5
(CH2), 43.6 (CH), 68.7 (C), 128.0 (CH), 128.6 (CH, 2C),
128.7 (CH, 2C), 135.4 (C), 174.7 (C), 176.5 (C), 202.0 (C),
213.4 (C); IR: m = 3461, 3033, 2964, 1775, 1742, 1704,
1601, 1497, 1431, 1400, 1352, 1314, 1287, 1208, 1167,
1084, 1028, 943, 699 cm-1; HRMS: m/z calcd for
C18H19NO4: 313.13141; found: 313.13121; elemental
analysis calcd (%) for C18H19NO4: C 69.01, H 6.07, N
4.47; found: C 68.96, H 6.11, N 4.42.
3-(3-acetyl-2-oxotetrahydrofuran-3-yl)-1-benzylpyrrol-
idine-2,5-dione, 4b: A colourless solid. [HPLC analysis on
a Daicel Chiralpak AD-H column: hexane/i-PrOH = 80/
20, flow rate 0.75 mL/min, k = 214 nm; major diastereo-
mer: sminor = 29.2 min, smajor = 37.7 min; minor diaste-
1
reomer: smajor = 21.8 min, sminor = 25.6 min]. H NMR
(CDCl3): d = 2.27 (s, 3H), 2.40–2.49 (m, 1H), 2.53 (dd,
J = 6.4, 18.4, 1H), 2.68–2.75 (m, 1H), 2.81 (dd, J = 9.2,
18.4, 1H), 3.35 (dd, J = 6.4, 9.2, 1H), 4.27–4.34 (m, 2H),
4.61 4.67 (AB, J = 14.4, 2H), 7.23–7.33 (m, 3H),
7.32–7.36 (m, 2H); 13C NMR (CDCl3): d = 25.9 (CH3),
28.7 (CH2), 31.7 (CH2), 42.1 (CH), 42.6 (CH2), 61.6 (C),
65.9 (CH2), 127.9 (CH), 128.5 (CH, 2C), 128.6 (CH, 2C),
135.3 (C), 173.6 (C), 174.4 (C), 176.1 (C), 200.7 (C); IR
(KBr): m = 3464, 3065, 3033, 2927, 1770, 1704, 1605,
1585, 1497, 1433, 1402, 1355, 1314, 1289, 1262, 1169,
1106, 1081, 1025, 975, 883, 696 cm-1; HRMS: m/z calcd
for C17H17NO5: 315.11067; found: 315.11085; elemental
analysis calcd (%) for C17H17NO5: C 64.76, H 5.40, N
4.44; found: C 64.65, H 5.48, N 4.42.
3-(2-acetyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)-1-
benzylpyrrolidine-2,5-dione, 4e: A colourless solid. [HPLC
analysis on a Daicel Chiralpak AD-H column: hexane/i-
PrOH = 75/25, flow rate 0.75 mL/min, k = 214 nm;
major diastereomer: sminor = 23.5 min, smajor = 22.8 min;
minor diastereomer: sminor = 26.8 min, smajor = 22.0
1
min]. H NMR (CDCl3): d = 2.19 (s,3H), 2.37–2.54 (m,
3H), 2.63 (dd, J = 6.0, 18.4, 1H), 2.98–3.03 (m, 2H), 3.30
(dd, J = 6.0, 9.2, 1H), 4.70 4.76 (AB, J = 14.4, 2H), 7.22-
7.37 (m, 5H), 7.39-7.45 (m, 2H), 7.52 (t, J = 7.6, 9.2, 1H),
8.07 (d, J = 7.6, 9.2, 1H); 13C NMR (CDCl3): d = 25.6
(CH2), 29.1 (CH3), 31.1 (CH2), 31.9 (CH2), 42.6 (CH2),
44.2 (CH), 65.5 (C), 127.4 (CH), 127.7 (CH), 128.1 (CH),
128.5 (CH, 2C), 128.6 (CH, 2C), 129.0 (CH), 132.1 (CH),
134.4 (C), 135.9 (C), 142.9 (C), 175.0 (C), 177.1 (C), 196.1
(C), 205.6 (C); IR (KBr): m = 3065, 3032, 2935, 1774,
1708, 1599, 1496, 1455, 1431, 1403, 1356, 1299, 1232,
Ethyl 2-(1-benzyl-2,5-dioxopyrrolidin-3-yl)-2-methyl-3-
oxobutanoate, 4c: A colourless foam. [HPLC analysis on a
Daicel Chiralpak AS-H column: hexane/i-PrOH = 75/25,
flow rate 0.75 mL/min, k = 214 nm; major diastereomer:
1171, 1160, 1078, 1045, 976, 913, 776, 700, 635 cm-1
;
123